Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer

NEXT STORY
iCAD Appoints Jeffrey Sirek as Senior Vice President and General Manager of Xoft
PREV STORY
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Lumenis Announces UltraPulse(R) With SCAAR FX(TM) Clinical Data to be Presented at the 16th European Burns Association Congress

HANOVER, Germany, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Lumenis Ltd. (NASDAQ:LMNS), the world's largest ...

author_avatar
NASDAQ Market News

Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology

Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids ...

author_avatar
NASDAQ Market News

Oncology Venture: Kallelse till extra bolagsstämma

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGNOTICE TO CONVENE EXTRAORDINARY GENERAL MEETINGKALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes ...

author_avatar
NASDAQ Market News